Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

R. Wilson; J. H. McKillop; D. W. M. Pearson; G. F. Cuthbert; J. A. Thomson

Research ArticleClinical Sciences

Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

R. Wilson, J. H. McKillop, D. W. M. Pearson, G. F. Cuthbert and J. A. Thomson

Journal of Nuclear Medicine September 1985, 26 (9) 1024-1028;

R. Wilson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. H. McKillop

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

D. W. M. Pearson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

G. F. Cuthbert

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

J. A. Thomson

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 26, Issue 9

September 1, 1985

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

R. Wilson, J. H. McKillop, D. W. M. Pearson, G. F. Cuthbert, J. A. Thomson

Journal of Nuclear Medicine Sep 1985, 26 (9) 1024-1028;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

R. Wilson, J. H. McKillop, D. W. M. Pearson, G. F. Cuthbert, J. A. Thomson

Journal of Nuclear Medicine Sep 1985, 26 (9) 1024-1028;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling
Can we predict relapse in Graves disease? Results from a systematic review and meta-analysis

Google Scholar

Main menu

User menu

Search

Relapse of Graves' Disease After Medical Therapy: Predictive Value of Thyroidal Technetium-99m Uptake and Serum Thyroid Stimulating Hormone Receptor Antibody Levels

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles